Elisabeth de Vries

Citado por

	Total	Desde 2019
Citas	111260	40240
Índice h	143	76
Índice i10	876	454

8000

4000

2000

6000

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024448 546 678 780 850 814 737 883 955 1182 1391 1606 2010 2470 2764 3001 2999 3464 3906 4770 4811 4944 5184 5856 5582 5847 6099 6965 7703 7546 6850 5050

Acceso público

Ver todo

164 artículos

10 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Steven de JongProfessor of Preclinical and Translational Oncology, University Medical Center GroningenDirección de correo verificada de umcg.nl
Marjolijn Lub-de HoogeUniversity Medical Center GroningenDirección de correo verificada de umcg.nl
Gietema JAProfessor of Medical Oncology, University Medical Center GroningenDirección de correo verificada de umcg.nl
Winette van der GraafProfessor of Personalised Oncology, the Institute of Cancer Research/Royal Marsen, London, UKDirección de correo verificada de icr.ac.uk
Geke HospersProfessor of medical oncologyDirección de correo verificada de umcg.nl
Sjoukje OostingMedical Oncologist, University Medical Center GroningenDirección de correo verificada de umcg.nl
Annemiek WalenkampDirección de correo verificada de umcg.nl
RSN FehrmannUniversity Medical Center GroningenDirección de correo verificada de umcg.nl
Derk Jan de GrootMD PhD, Medical oncologist, University Medical Center GroningenDirección de correo verificada de umcg.nl
Jos KosterinkHoogleraar Hospital and Clinical Pharmacy, UMCG, RUG GroningenDirección de correo verificada de umcg.nl
A GlaudemansUniversity Medical Center GroningenDirección de correo verificada de umcg.nl
Nathan I. ChernyShaare Zedek Medical CenterDirección de correo verificada de netvision.net.il
G J te Meermanemeritus associate professor in mathematical genetics and bioinformatics, researcher geneticsDirección de correo verificada de umcg.nl
Lesley SeymourQueens UniversityDirección de correo verificada de ctg.queensu.ca
Marian J.E. MouritsProfessor Gynecologic Oncology, University Medical Center GroningenDirección de correo verificada de umcg.nl
HM Boezensearch "Boezen or Marike Boezen''Dirección de correo verificada de umcg.nl
Marcel van VugtProfessor of Molecular Oncology, University of Groningen, University Medical CentreDirección de correo verificada de umcg.nl
Pieter PostmusLUMCDirección de correo verificada de lumc.nl
Frederike BenschUniversity Medical Center GroningenDirección de correo verificada de umcg.nl
Urania DafniProfessor of Biostatistics, National and Kapodistrian University of Athens, GreeceDirección de correo verificada de nurs.uoa.gr

Seguir

Elisabeth de Vries

Professor of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands

Dirección de correo verificada de umcg.nl


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 365 (9472), 1687-1717, 2005	7882	2005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005	6280	2005
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 … Early Breast Cancer Trialists' Collaborative Group The Lancet 378 (9804), 1707-1716, 2011	3988	2011
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials EBCTC Group The lancet 378 (9793), 771-784, 2011	3844*	2011
Everolimus for advanced pancreatic neuroendocrine tumors JC Yao, MH Shah, T Ito, CL Bohas, EM Wolin, E Van Cutsem, TJ Hobday, ... New England Journal of Medicine 364 (6), 514-523, 2011	3404	2011
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ... The Lancet Oncology 18 (3), e143-e152, 2017	2095	2017
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … DLW Kwong, P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, ... The Lancet, 2014	1951	2014
RECIST 1.1—Update and clarification: From the RECIST committee LH Schwartz, S Litière, E De Vries, R Ford, S Gwyther, S Mandrekar, ... European journal of cancer 62, 132-137, 2016	1635	2016
20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years H Pan, R Gray, J Braybrooke, C Davies, C Taylor, P McGale, R Peto, ... New England Journal of Medicine 377 (19), 1836-1846, 2017	1536	2017
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015	1343	2015
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo … ME Pavel, JD Hainsworth, E Baudin, M Peeters, D Hörsch, RE Winkler, ... The Lancet 378 (9808), 2005-2012, 2011	1195	2011
Response assessment criteria for brain metastases: proposal from the RANO group NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ... The lancet oncology 16 (6), e270-e278, 2015	913	2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical … NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ... Annals of Oncology 26 (8), 1547-1573, 2015	905	2015
Biodistribution of ⁸⁹Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ... Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010	904	2010
Evidence based selection of housekeeping genes HJM de Jonge, RSN Fehrmann, ESJM de Bont, RMW Hofstra, F Gerbens, ... PloS one 2 (9), e898, 2007	856	2007
Overexpression of a M_r 110,000 Vesicular Protein in Non-P-Glycoprotein-mediated Multidrug Resistance RJ Scheper, HJ Broxterman, GL Scheffer, P Kaaijk, WS Dalton, ... Cancer research 53 (7), 1475-1479, 1993	841	1993
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. M Müller, C Meijer, GJ Zaman, P Borst, RJ Scheper, NH Mulder, ... Proceedings of the National Academy of Sciences 91 (26), 13033-13037, 1994	785	1994
Radiolabeled amino acids: basic aspects and clinical applications in oncology PL Jager, W Vaalburg, J Pruim, EGE de Vries, KJ Langen, DA Piers Journal of nuclear medicine 42 (3), 432-445, 2001	770	2001
A review on CXCR4/CXCL12 axis in oncology: no place to hide UM Domanska, RC Kruizinga, WB Nagengast, H Timmer-Bosscha, ... European journal of cancer 49 (1), 219-230, 2013	722	2013
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1353-1361, 2015	674	2015

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores